What Happened?
South San Francisco, CA-based InterVenn Appointed Brian Hogan as Chief Financial Officer
About the Company
InterVenn Biosciences utilizes a proprietary high-throughput glycoproteomic interrogation platform using artificial intelligence and mass spectrometry for next-gen precision medicine. The company is working to find new solutions in ovarian, pancreatic, liver, prostate, and kidney cancer, together with applications from the Vista suite of solutions for treatment and monitoring, immune profiling, patient stratification, and disease progression.
About the Person
Brian Hogan is Chief Financial Officer at InterVenn. Previously, Brian held various senior HR leadership roles in the industry.
Info Source
News
Short Profile